Chief Medical Officer · ZEVRA THERAPEUTICS, INC. · Common Stock
Side
SELL
Value
$40K
Shares
4,533
Price
$8.83
Executed
Jan 30, 2026
Disclosed
Feb 2, 2026
Disclosure timeline3 days from execution to publication · legal deadline 2 business days
Jan 30 executedFeb 2, 2026 disclosed
ZVRA · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering+5 / 15
1 other actor traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Quartel Adrian W filed this Form 4 reporting a open-market sale of ZVRA on Jan 30, 2026. It became public on Feb 2, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Medical Officer
Quartel Adrian Wcik:0001910132
Issuer
ZEVRA THERAPEUTICS, INC.cik:0001434647
Revision history · 0
No field has changed since this record was first ingested.
